These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37880985)

  • 21. BCR::ABL1-induced mitochondrial morphological alterations as a potential clinical biomarker in chronic myeloid leukemia.
    Suzuki K; Watanabe N; Torii S; Arakawa S; Ochi K; Tsuchiya S; Yamada K; Kawamura Y; Ota S; Komatsu N; Shimizu S; Ando M; Takaku T
    Cancer Sci; 2024 Dec; ():. PubMed ID: 39652455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutation.
    Quezada Meza CP; Salizzato V; Calistri E; Basso M; Zavatti M; Marmiroli S; Salvi M; Carter BZ; Donella-Deana A; Borgo C; Ruzzene M
    Int J Biol Macromol; 2024 Dec; 286():138305. PubMed ID: 39631575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression.
    Li W; Hu S; Tian C; Wan X; Yu W; Guo P; Zhao F; Hua C; Lu X; Xue G; Han S; Guo W; Wang D; Deng W
    Free Radic Biol Med; 2021 Dec; 177():31-47. PubMed ID: 34648907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gambogic acid impairs the maintenance and therapeutic resistance of glioma stem cells by targeting B-cell-specific Moloney leukemia virus insert site 1.
    Sun T; Lin B; Sun Q; Zhang X; Wang T; Yang J; Liu X; Lu H; Lu N; Zhao K
    Phytomedicine; 2024 Dec; 135():156070. PubMed ID: 39326139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.
    Pan C; Olsen JV; Daub H; Mann M
    Mol Cell Proteomics; 2009 Dec; 8(12):2796-808. PubMed ID: 19651622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerated-phase CML: de novo and transformed.
    Shanmuganathan N; Hughes TP
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):459-468. PubMed ID: 38066863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic Effects of Inecalcitol With Imatinib and Dasatinib on Chronic Myeloid Leukemia Cell Lines.
    Angel S; Cowles E; Costa J; Ani RA; Venkatachalam KV
    Anticancer Res; 2024 Dec; 44(12):5193-5197. PubMed ID: 39626944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML).
    Laganà A; Scalzulli E; Bisegna ML; Ielo C; Martelli M; Breccia M
    Expert Rev Hematol; 2024 Dec; ():1-15. PubMed ID: 39647915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells.
    Weber SM; Brossier NM; Prechtl A; Barnes S; Wilson LS; Brosius SN; Longo JF; Carroll SL
    Cell Commun Signal; 2021 Sep; 19(1):95. PubMed ID: 34530870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Cytomegalovirus Induces Vitamin-D Resistance In Vitro by Dysregulating the Transcriptional Repressor Snail.
    Stecher C; Maurer KP; Kastner MT; Steininger C
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research on the clinical characteristics and prognosis of children with chronic myeloid leukemia in the blast phase].
    Zheng FY; Lu AD; Jia YP; Zuo YX; Zeng HM; Jiang Q; Zhang LP
    Zhonghua Xue Ye Xue Za Zhi; 2024 Oct; 45(10):931-936. PubMed ID: 39622757
    [No Abstract]   [Full Text] [Related]  

  • 32. CDC42 deficiency leads to endometrial stromal cell senescence in recurrent implantation failure.
    Tang X; Zhu Y; Cao Z; Wang X; Cai X; Tang Y; Zhou J; Wu M; Zhen X; Ding L; Yan G; Wang H; Sun H; Jiang R
    Hum Reprod; 2024 Dec; 39(12):2768-2784. PubMed ID: 39487595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia.
    Kimura H; Onozawa M; Yoshida S; Miyashita N; Yokoyama S; Matsukawa T; Hirabayashi S; Goto H; Endo T; Oguri S; Fujisawa S; Mori A; Kondo T; Hidaka D; Okada K; Ota S; Kakinoki Y; Tsutsumi Y; Yamamoto S; Miyagishima T; Hashiguchi J; Nagashima T; Ibata M; Wakasa K; Haseyama Y; Fujimoto K; Ishihara T; Sakai H; Teshima T
    Ann Hematol; 2023 Nov; 102(11):3103-3113. PubMed ID: 37597110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LCCP exposure leads to skin cell senescence damage by triggering oxidative stress mediated by mitochondrial Ca
    Zhang M; Zhang R; Kong Y; Li J; Wang G; Wu D; Wu M; Lan H
    Int Immunopharmacol; 2024 Dec; 143(Pt 2):113471. PubMed ID: 39467346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCR::ABL1 Deep Molecular Response Quantification and Transcript Type Identification in Chronic Myeloid Leukemia Using a US Food and Drug Administration-Approved Droplet-Based Digital PCR Assay.
    Kockerols C; Valk PJM; Hogenbirk P; Cornelissen JJ; Westerweel PE
    J Mol Diagn; 2024 Nov; ():. PubMed ID: 39615652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caulerpin alleviates cyclophosphamide-induced ovarian toxicity by modulating macrophage-associated granulosa cell senescence during breast cancer chemotherapy.
    Ren X; Yao B; Zhou X; Nie P; Xu S; Wang M; Li P
    Int Immunopharmacol; 2024 Dec; 143(Pt 3):113513. PubMed ID: 39486187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-escalation of second-line and first-line asciminib in chronic myeloid leukemia in chronic phase: the ASC2ESCALATE Phase II trial.
    Atallah EL; Mauro MJ; Sasaki K; Levy MY; Koller P; Yang D; Laine D; Sabo J; Gu E; Cortes JE
    Future Oncol; 2024; 20(38):3065-3075. PubMed ID: 39387441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study.
    Bernardi S; Cavalleri A; Mutti S; Garuffo L; Farina M; Leoni A; Iurlo A; Bucelli C; Toffoletti E; Di Giusto S; Tiribelli M; Scaffidi L; Binotto G; Malagola M; Russo D; Bonifacio M
    Ann Hematol; 2024 Nov; ():. PubMed ID: 39611878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SGLT2 inhibitor downregulates ANGPTL4 to mitigate pathological aging of cardiomyocytes induced by type 2 diabetes.
    Wen Y; Zhang X; Liu H; Ye H; Wang R; Ma C; Duo T; Wang J; Yang X; Yu M; Wang Y; Wu L; Zhao Y; Wang L
    Cardiovasc Diabetol; 2024 Dec; 23(1):430. PubMed ID: 39633372
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.